We are live on ! Find out more
NRXPW

NRX Pharmaceuticals Warrant
NRXPW

Delisted

NRXPW was delisted on the 22nd of May, 2026.

Back to rankings

3 hedge funds and large institutions have $5.3K invested in NRX Pharmaceuticals Warrant in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.08% less ownership

Funds ownership: 0.51% → 0.43% (-0.08%)

14% less capital invested

Capital invested by funds: $6.16K → $5.3K (-$862)

25% less funds holding

Funds holding: 4 → 3 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
+$121
2
UBS Group
UBS Group
Switzerland
+$38

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Truist Financial
1
Truist Financial
North Carolina
$3.32K – – –
WAM
2
Wolverine Asset Management
Illinois
$1.85K +$121 +1,500 +7%
UBS Group
3
UBS Group
Switzerland
$128 +$38 +468 +45%
VF
4
Virtu Financial
New York
– -$1K -13,967 Closed

NRXPW Hedge Fund Activity: Q2 2025 in Review

3 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q2 2025, worth a combined $5.3K — down 14% from $6.16K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of NRXPW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.

The largest buyer was Wolverine Asset Management, adding an estimated $121. The largest seller was Virtu Financial, exiting entirely with an estimated $1K sold.

  • 3 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q2 2025, down from 4 in Q1 2025.
  • Funds reported $5.3K of NRX Pharmaceuticals Warrant stock for Q2 2025, down 14% quarter-over-quarter.
  • 0 funds opened new NRX Pharmaceuticals Warrant positions in Q2 2025 and 1 closed out, a net change of -1 holder.
  • The largest NRX Pharmaceuticals Warrant buyer in Q2 2025 was Wolverine Asset Management, an estimated $121 added.
  • The largest NRX Pharmaceuticals Warrant seller in Q2 2025 was Virtu Financial, an estimated $1K sold.

Based on aggregated 13F filings for Q2 2025.